Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest Laboratories Inc., and Peregrine Pharma Inc.

 Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest
                 Laboratories Inc., and Peregrine Pharma Inc.

PR Newswire

LONDON, September 6, 2013

LONDON, September 6, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Thursday, September 5, 2013, the U.S. equity market posted gains. The S&P
500 gained 0.12%, while the Dow Jones Industrial Average and the NASDAQ
Composite rose 0.04% and 0.27% respectively. Shares of companies in the
healthcare sector ended on a mixed note, even as the broader market edged
higher. The major movers included Celgene Corporation (NASDAQ: CELG), Edwards
Lifesciences Corporation (NYSE: EW), Forest Laboratories Inc. (NYSE: FRX), and
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). AAAResearchReports.com has
released free charting and technical research on these aforementioned
companies. Register to read these reports at:

http://www.aaaresearchreports.com/register/ 

Celgene Corporation's stock edged lower on Thursday, even as the broader
market advanced. The company's shares closed the day 0.33% lower
at$145.59after oscillating between$145.01 and $147.76. A total of 2.13
million shares were traded, which is below the daily average volume of 2.62
million. Despite Thursday's pullback, Celgene Corporation's shares have gained
4.01% in the previous three trading sessions and 29.76% in the last three
months, outperforming the S&P 500 during both periods. Further, the company's
stock is currently trading above its 50-day and 200-day averages of $135.20
and $112.40 respectively. Sign up for free report on CELG at:

http://www.AAAResearchReports.com/CELG090613.pdf

On Thursday, shares in Edwards Lifesciences Corporation gained 0.60%,
extending their gains from previous trading sessions. The company's stock
fluctuated between $71.24 and $72.31 to end the day at $71.79. A total of 0.70
million shares were traded, which is below the daily average volume of 1.03
million. Edwards Lifesciences Corporation's shares have gained 7.84% in the
last three months, compared to a gain of 2.87% in the S&P 500 during the same
period. Additionally, the company's stock is trading above its 50-day moving
average of $69.74. EW free technical report can be accessed by signing up at:

http://www.AAAResearchReports.com/EW090613.pdf

On Thursday, Forest Laboratories Inc.'s stock fell by 0.14% from the previous
day's closing price of $43.40, after rising sharply in the previous trading
session. The company's shares ended the day at$43.34after fluctuating
between$43.15 and$43.93. A total of 1.11 million shares were traded, which
is below the daily average volume of 1.43 million. Despite Thursday's
pullback, Forest Laboratories Inc.'s stock is up 1.90% in the previous three
trading sessions and 8.49% in the last three months, outperforming the S&P 500
which has gained 1.35% and 2.87% during the respective periods. Moreover, the
company' stock is trading above its 50-day and 200-day moving averages of
$43.09 and $38.63 respectively. A free report on FRX can be accessed by
registering at:

http://www.AAAResearchReports.com/FRX090613.pdf

Shares in Peregrine Pharmaceuticals Inc. rose sharply on Thursday, extending
their gains from previous trading sessions. The company's shares vacillated
between$1.41 and$1.45before finishing the day 2.13% higher at$1.44. A
total of 1.45 million shares were traded, which is below the daily average
volume of 1.73 million. Peregrine Pharmaceuticals Inc.'s shares have advanced
5.11% in the last three trading sessions, compared to a gain of 1.35% in the
S&P 500 during the same period. Furthermore, the company's stock is trading
above its 50-day moving average of $1.43. Register with AAA Research Reports
and download research on PPHM for free at:

http://www.AAAResearchReports.com/PPHM090613.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by an analyst. However, we are only human and are prone
    to make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through analysts, only reviewed
the information provided by Equity News Network in this article or report
according to the Procedures outlined by Equity News Network. Equity News
Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

http://AAAresearchreports.com



SOURCE AAA Research Reports

Contact: Phone #: + 1 (646) 396-9126 - Contact Name: Peter F. Jones - Email
ID: info@aaaresearchreports.com
 
Press spacebar to pause and continue. Press esc to stop.